Ciclindole

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Ciclindole
Ciclindole.png
Clinical data
Routes of
administration
Oral
ATC code
  • none
Legal status
Legal status
  • In general: uncontrolled
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
Chemical and physical data
Formula C14H18N2
Molar mass 214.31 g/mol
3D model (JSmol)

Ciclindole (INN; WIN-27,147-2), also known as cyclindole (USAN), is an antipsychotic with a tricyclic structure that was never marketed.[1][2] It displaces spiperone binding in vitro and elevates dopamine levels in the striatum, indicating it acts as a D2 receptor antagonist.[2]

Synthesis[edit]

Cyclindole synthesis: Aram Mooradian; Sterling Drug Inc. U.S. Patent 3,959,309

See also[edit]

References[edit]

  1. ^ David J. Triggle (1996). Dictionary of Pharmacological Agents. Boca Raton: Chapman & Hall/CRC. ISBN 0-412-46630-9. 
  2. ^ a b Wood PL, McQuade PS (1984). "Ciclindole and flucindole: novel tetrahydrocarbazolamine neuroleptics". Progress in Neuro-psychopharmacology & Biological Psychiatry. 8 (4-6): 773–7. PMID 6152347. doi:10.1016/0278-5846(84)90057-5.